Ligand · DVI
DVI · methyl (1S,3S)-1-methyl-3-[[3-[[3-methyl-4-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]carbamoyl]-4-oxidanylidene-cyclohexane-1-carboxylate
DVI, methyl (1S,3S)-1-methyl-3-[[3-[[3-methyl-4-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]carbamoyl]-4-oxidanylidene-cyclohexane-1-carboxylate (C33 H32 N6 O5, 592.6 g/mol), in the MolNFT structures on GenesisL1: bound in…
- Component
- DVI
- Formula
- C33 H32 N6 O5
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
DVI in 1 structure; the first of them:
- 8PT9 · JNK1 covalently bound to BD838 cyclohexe based inhibitor · DVI A401 · binds ILE32, SER34, GLY35, ALA36, GLN37, VAL40, ALA53, GLU109 and 10 more
Residues it binds most
ALA 3, GLN 3, LEU 3, SER 3, VAL 3, MET 3, ASN 3, ASP 3, CYS 3, GLU 3 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.